November 16, 2026
- Dick Boer, former President and CEO of Ahold Delhaize, proposed as new member and Vice-Chairman of Philips’ Supervisory Board
- Laurence Debroux, former CFO of Heineken, proposed as new member and Chair of the Audit Committee
- Todd Brinton, Chief Scientific Officer and Corporate Vice President, Advanced Innovation & Technology at Edwards Lifesciences, proposed as new member of Philips’ Supervisory Board
- Paul Stoffels, Liz Doherty and Sanjay Poonen to retire from Philips’ Supervisory Board at the close of the 2027 Annual General Meeting of Shareholders
- John DeFord to succeed Paul Stoffels as Chair of the Quality & Regulatory Committee
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it will propose the appointments of Dick Boer, Laurence Debroux and Todd Brinton as new members of the Supervisory Board at the 2027 Annual General Meeting of Shareholders (AGM).
Dick Boer (Dutch, 1957) served as President and Chief Executive Officer of Ahold and, following the merger with Delhaize, as President and Chief Executive Officer of Ahold Delhaize until 2018. He also served as Chairman of the Supervisory Board of Just Eat Takeaway from 2022 until the end of 2025. He is currently Deputy Chair and Senior Independent Director of Shell plc and Lead Independent Director and Vice Chair of Nestlé S.A. Subject to his appointment by shareholders, Dick Boer will become Vice-Chairman of Philips’ Supervisory Board, succeeding Paul Stoffels.
Laurence Debroux (French, 1969) was Chief Financial Officer and member of the Executive Board of Heineken from 2015 to 2021 and previously Chief Financial Officer at JCDecaux and Sanofi. She currently serves on the boards of Randstad, where she chairs the Audit Committee, and Coca-Cola Europacific Partners. She has previously held other non-executive positions in listed companies, including as independent director of Exor from 2017 until May 2026. Subject to her appointment by shareholders, Laurence Debroux will succeed Liz Doherty as Chair of Philips’ Audit Committee.
Todd J. Brinton MD (American, 1969) is currently Chief Scientific Officer and Corporate Vice President, Advanced Innovation & Technology at Edwards Lifesciences. Previously, he was Clinical Professor of Medicine & Adjunct Professor of Bioengineering, as well as attending Interventional cardiologist at Stanford University. He founded several cardiovascular device companies including Shockwave Medical where he served as Chief Medical Officer.
Paul Stoffels, Vice-Chairman of the Supervisory Board and Chair of the Quality & Regulatory Committee, will retire at the close of the 2027 AGM, after nine years on the Supervisory Board and ahead of the end of his current term, enabling the planned succession in both roles. Liz Doherty, Chair of the Audit Committee, whose current term ends at the close of the 2027 AGM, will also retire from the Supervisory Board at that time. Sanjay Poonen, Member of the Supervisory Board will also retire at the close of 2027 AGM, ahead of the end of his current second term so that he can focus on other Boards. John DeFord will succeed Paul Stoffels as Chair of the Quality & Regulatory Committee.
“We are pleased to propose Dick Boer, Laurence Debroux and Todd Brinton to join Philips’ Supervisory Board,” said Feike Sijbesma, Chairman of the Supervisory Board of Royal Philips. “Together, they bring complementary international business, financial, governance and medtech expertise that will further strengthen the Supervisory Board. Dick’s extensive business, leadership and governance background will reinforce the Board’s leadership. Laurence brings deep financial and international governance expertise, including from the life sciences sector, while Todd adds the perspective of an experienced medtech executive, physician and innovator. John DeFord’s extensive medtech, quality and regulatory expertise will also support his leadership of the Quality & Regulatory Committee. I would also like to thank Paul Stoffels, Liz Doherty and Sanjay Poonen for their valuable contributions and leadership during their time on the Board.”
The agenda for the 2027 AGM, including the proposals to appoint Dick Boer, Laurence Debroux and Todd Brinton as members of the Supervisory Board and the accompanying explanatory notes, will be published in due course in accordance with applicable legal and regulatory requirements.
For further information, please contact:
Michael Fuchs
Philips Global External Relations
Tel.: +31 6 1486 9261
E-mail: michael.fuchs@philips.com
Dorin Danu
Philips Investor Relations
Tel.: +31 20 59 77055
E-mail: dorin.danu@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in image-guided therapy, diagnostic imaging, ultrasound, monitoring, enterprise informatics and personal health. Philips generated 2025 sales of approximately EUR 18 billion and employs approximately 63,900 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter
Forward-looking statements
This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips’ organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.
Attachments
-
NABEP 选择苏尔寿重建 2025 年事件中被摧毁的彼得罗塞德尼奥塔这家瑞士领先的工程公司将在奥里诺科地带设施制造和安装一座新塔,这是恢复委内瑞拉加工超重原油能力的关键一步。重建项目旨在支持该国基本产业的发展和可靠性。2026-11-16
-
CeraVe 首次携手电影《Dune: Part Three》,成为“Arrakis 官方指定保湿霜”这场全球营销活动通过一系列面向社交平台的视频,将 CeraVe 与皮肤科医生共同研发、提供 120 小时保湿效果的保湿霜,带入 Dune 的史诗电影世界。 * CeraVe 宣布与2026-11-16
-
DANIEL WELLINGTON 佳节献礼,致意最珍视的人从日常钟爱之选到瞩目佳作,2026 年节日礼赠指南汇集为心中珍视之人悉心甄选的腕表与珠宝。 斯德哥尔摩2026年11月16日 美通社 -- 一份契合收礼人个性的礼物,更能传递2026-11-16
-
周大生珠宝以千里江山系列,再现东方山河盛景少年执笔,丹青留名。北宋天才画家王希孟留下传世名作《千里江山图》,用一卷青绿道尽山河壮阔。浓淡晕染间,层峦江山、浩渺烟波尽数落于画卷,娓娓诉说独属于华夏文明2026-11-16
-
interpack China 2026包装世界(上海)博览会今日盛大启幕,全球包装产业链资源汇聚上海上海2026年11月16日 美通社 -- 2026年11月16日,由杜塞尔多夫展览(上海)有限公司和雅式展览服务有限公司共同主办的interpack China 2026包装世界(上海)博览会在上海新国2026-11-16
-
AMD股价暴跌17%创近9年之最,苏姿丰紧急回应:AI增速远超想象
-
锚定健康中国新征程!第一届医药信息传播论坛将于广州启幕
-
Ledger 中国销售渠道说明:广州馨潇贸易有限公司官方直营渠道公示
-
江苏省脑机接口产业联盟在宁成立,麦澜德分享前沿成果
-
艾芬达入选国家知识产权强国建设示范创建对象:二十载长期主义,兑现每一份用户价值
-
Esentia宣布成功完成2033年到期的6.125%优先票据和2038年到期的6.500%优先票据的定价
-
中荷人寿北京分公司成功举办中荷创享家品牌发布暨协同发展启航仪式
-
华为系具身智能公司具脑磐石完成新一轮融资:对标JEPA,押注类脑智能的认知世界模型
-
北京暑假补习班有哪些?家长首推一对一权威机构金博升学
-
上海高新技术企业代理机构深度访谈与推荐
